Role of molecular diagnostic testing in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer families.
OBJECTIVE
Genetic tests are available for familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer. The goal of this review was to develop an algorithm for application of molecular diagnostic techniques to the management of hereditary colorectal carcinoma and to familiarize the clinician with the vocabulary of molecular genetic testing for hereditary colorectal carcinoma.


METHODS
Studies examining the clinical use of genetic testing for hereditary colorectal carcinoma syndromes are evaluated. Recent advances in molecular genetic technology are reviewed, and clinical management as practiced here and elsewhere is outlined.


RESULTS
This review is a guide to the most reliable molecular diagnostic techniques. Three key questions are answered: who, when, and how to test.


CONCLUSIONS
When integrated with existing testing protocols for colorectal carcinoma and when applied with appropriate caveats, particularly regarding interpretation of negative results, genetic testing can result in improved management of patients and families.
Rabelo
R
R
Department of Medical Biochemistry, Sir Mortimer B. Davis-Jewish General Hospital and McGill University, Montreal, Quebec, Canada.
Foulkes
W
W
Gordon
P H
PH
Wong
N
N
Yuan
Z Q
ZQ
MacNamara
E
E
Chong
G
G
Pinsky
L
L
Lasko
D
D
D011125:Adenomatous Polyposis Coli / Q000175:diagnosis* / Q000235:genetics; D000465:Algorithms; D003123:Colorectal Neoplasms, Hereditary Nonpolyposis / Q000175:diagnosis* / Q000235:genetics; D004252:DNA Mutational Analysis; D005817:Genetic Counseling; D005820:Genetic Testing; D006801:Humans; D011237:Predictive Value of Tests